Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012:11:147-56.
doi: 10.4137/CIN.S9983. Epub 2012 Jul 24.

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Xi Chen  1 , Jiang Li, William H Gray, Brian D Lehmann, Joshua A Bauer, Yu Shyr, Jennifer A Pietenpol
Affiliations
Case Reports

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Xi Chen et al. Cancer Inform. 2012.

Abstract

Motivation: Triple-negative breast cancer (TNBC) is a heterogeneous breast cancer group, and identification of molecular subtypes is essential for understanding the biological characteristics and clinical behaviors of TNBC as well as for developing personalized treatments. Based on 3,247 gene expression profiles from 21 breast cancer data sets, we discovered six TNBC subtypes from 587 TNBC samples with unique gene expression patterns and ontologies. Cell line models representing each of the TNBC subtypes also displayed different sensitivities to targeted therapeutic agents. Classification of TNBC into subtypes will advance further genomic research and clinical applications.

Result: We developed a web-based subtyping tool TNBCtype for candidate TNBC samples using our gene expression meta data and classification methods. Given a gene expression data matrix, this tool will display for each candidate sample the predicted subtype, the corresponding correlation coefficient, and the permutation P-value. We offer a user-friendly web interface to predict the subtypes for new TNBC samples that may facilitate diagnostics, biomarker selection, drug discovery, and the more tailored treatment of breast cancer.

Keywords: classification; gene expression microarray; meta-analysis; subtypes; triple-negative breast cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Workflow for developing the TNBC subtype gene signature. Notes: After breast cancer gene expression data collection, three major procedures were performed to develop TNBC gene signature. First, TNBC identification by bimodal filtering on ER, PR and HER2 expression. Second, clustering analysis to develop TNBC subtypes. Finally, validation for TNBC subtypes and gene signature.
Figure 2
Figure 2
ER positive samples dramatically affect TNBC subtype prediction results. (A) Prediction results for TNBC samples normalized without any ER positive sample; (B) Prediction results for the same TNBC samples normalized in the presence of ER positive samples.
Figure 3
Figure 3
ER gene expression for TNBC and ER positive samples. Note: Boxplot shows the ER gene expression percentile among all genes within a given sample.
Figure 4
Figure 4
Snapshot of TNBC prediction outcome. Notes: For illustration, a cohort with 26 publicly available TNBC samples was tested by TNBC type. Six colors were selected to represent each of the six TNBC subtypes. The table on the left shows the predicted subtype assigned to each sample, the correlation with the corresponding subtype centroid, and the P-value from 1,000 permutations. The color bars on the right show the same information as the table. The height of the bars indicates the magnitude of the correlation coefficients.
See this image and copyright information in PMC

References

    1. Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? J Clin Oncol. 2005 Oct 10;23(29):7350–60. - PubMed
    1. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients—A single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results Database. Cancer. 2007 Aug 15;110(4):876–84. - PubMed
    1. Haffty BG, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2006 Dec 20;24(36):5652–7. - PubMed
    1. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429–34. - PubMed
    1. Foulkes WD, Smith IE, Reis JS. Triple-Negative Breast Cancer. New Engl J Med. 2010 Nov 11;363(20):1938–48. - PubMed

Publication types

LinkOut - more resources